https://it.marketscreener.com/quotazioni/azione/IVERIC-BIO-INC-57355605/attualita/Iveric-Bio-annuncia-l-analisi-post-hoc-dello-studio-clinico-GATHER1-di-Zimura-al-meeting-della-Soc-41006756/?utm_source=telegram&utm_medium=social&utm_campaign=share